Flutamide

Prostate Cancer Treatment

Flutamide is primarily used to treat metastatic prostate cancer, which is cancer that has spread from the prostate gland to other areas of the body. It is specifically indicated for the treatment of Stage D2 metastatic prostatic carcinoma.

This medication is not usually used alone. It is typically prescribed as part of a combination therapy that includes other medications known as luteinizing hormone-releasing hormone (LHRH) agonists. These medications work together to manage the growth of cancer cells that rely on male hormones to spread.

Common situations where flutamide may be prescribed include:

• Managing advanced prostate cancer that has reached a metastatic stage.
• Initial treatment of prostate cancer in combination with LHRH analogs to help block the effects of testosterone in the body.

Mechanism of Action

Flutamide belongs to a class of drugs known as nonsteroidal antiandrogens. It is primarily used to treat prostate cancer, a condition where cancer cells often depend on male hormones (androgens) to multiply and spread.

The medication works through the following processes:

• Blocking Hormone Receptors: Flutamide prevents androgens, such as testosterone, from binding to specific receptors on the surface of prostate cancer cells.
• Inhibiting Hormone Uptake: It interferes with the ability of cancer cells to take up and use these hormones.
• Slowing Cancer Growth: By cutting off the hormonal signals that stimulate the cancer, the drug helps to slow down or stop the growth and spread of the disease.

Because prostate cancer is sensitive to androgens, reducing the influence of these hormones is a common strategy for managing the condition. Flutamide is often used alongside other treatments that lower the overall production of testosterone in the body to provide a more complete blockade of male hormones.

Common Side Effects

The most frequently reported side effects of flutamide include:

• Hot flashes
• Breast enlargement (gynecomastia) or breast tenderness
• Nausea and vomiting
• Diarrhea
• Decreased interest in sex or difficulty achieving an erection
• Loss of appetite
• Increased sensitivity of the skin to sunlight

Serious Side Effects

Seek medical attention immediately if you notice any of the following serious symptoms:

• Liver injury: Yellowing of the skin or the whites of the eyes (jaundice), dark amber or tea-colored urine, persistent nausea, or pain in the upper right part of the abdomen.
• Blood disorders: Bluish tint to the skin, lips, or fingernails, which may be a sign of methemoglobinemia (a condition that reduces oxygen in the blood).
• Breathing difficulties: Sudden shortness of breath, wheezing, or a new or worsening cough.
• Infection: Fever, chills, or other flu-like symptoms.
• Fluid retention: Swelling of the hands, feet, or lower legs.
• Unusual bleeding: Easy bruising or bleeding that is difficult to stop.

Liver Injury

Flutamide has been associated with severe liver injury, including liver failure and death. Healthcare providers typically monitor liver function through blood tests before starting treatment and at regular intervals during therapy. Treatment is usually stopped if liver enzymes reach a certain level or if signs of liver damage appear.

Contraindications

• Severe liver disease: This medication should not be used by individuals with pre-existing severe hepatic impairment.
• Pregnancy: Flutamide is not indicated for use in women and may cause fetal harm if taken during pregnancy.
• Hypersensitivity: It should not be used by anyone with a known allergy to flutamide or its components.

Other Precautions

Anemia: Long-term use may lead to a decrease in hemoglobin and hematocrit levels. Blood counts may be monitored periodically.

Glucose Tolerance: Some patients may experience changes in blood sugar levels. Individuals with diabetes may need closer monitoring of their blood glucose.

Methemoglobinemia: Rare instances of blood disorders, such as methemoglobinemia, have been reported, particularly in patients with certain genetic conditions like glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Photosensitivity: The skin may become more sensitive to sunlight while taking this medication. Protective measures against UV exposure are often recommended.

Pregnancy

Flutamide is indicated for use only in male patients. It is not for use in women, particularly those who are or may become pregnant. Clinical data and animal studies indicate that flutamide can cause significant harm to a fetus. In animal research, exposure to the medication during pregnancy resulted in developmental issues, including the feminization of male offspring.

Because of these risks, flutamide is contraindicated in pregnancy. Men who are taking flutamide and have partners who can become pregnant should use effective contraception during treatment and for a period of time after the final dose to prevent pregnancy.

Breastfeeding

It is not known whether flutamide or its components pass into human breast milk. Because the drug is not indicated for use in women, there is no established safety information regarding its use while breastfeeding. Individuals should discuss any concerns with their healthcare provider.

Dosage Forms

Flutamide is available as an oral medication in the following form:

• Capsule: This medication is taken by mouth, typically several times a day as part of a specific treatment plan directed by a healthcare professional.

FDA Approval and Indications

Flutamide is approved by the U.S. Food and Drug Administration (FDA) for the treatment of metastatic prostatic carcinoma (Stage D2). It is indicated for use in combination with luteinizing hormone-releasing hormone (LHRH) agonists, such as leuprolide acetate.

Boxed Warning

The FDA-approved labeling for flutamide includes a boxed warning concerning the risk of serious liver injury. Post-marketing reports have documented cases of hospitalization, liver failure, and death associated with its use. Hepatic injury may occur at any time during treatment, although it often presents within the first few months of therapy.

Regulatory Requirements and Monitoring

Due to the risk of hepatotoxicity, the FDA requires specific monitoring protocols for patients prescribed flutamide:

• Liver Function Testing: Periodic serum transaminase testing is necessary. Testing is recommended before starting treatment, monthly for the first four months, and periodically thereafter.
• Symptom Reporting: Patients are advised to seek immediate medical attention if they experience symptoms of liver dysfunction, such as jaundice, dark urine, or persistent right upper quadrant pain.
• Discontinuation: Treatment should be discontinued if liver enzyme levels rise significantly (typically two times the upper limit of normal) or if clinical jaundice develops.

Pharmacogenomic Considerations

The FDA identifies flutamide as a drug with pharmacogenomic biomarkers in its labeling. Specifically, caution is advised for individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. These patients may be at an increased risk of developing hemolytic anemia or methemoglobinemia while taking this medication.

Factors Influencing Cost

The price of flutamide can vary based on the following factors:

• Generic Availability: Flutamide is available as a generic medication. Generic versions are typically less expensive than brand-name drugs while containing the same active ingredients.
• Insurance Coverage: Many health insurance plans and Medicare Part D cover flutamide. The actual out-of-pocket cost will depend on the specific plan's deductible, copayment, or coinsurance requirements.
• Pharmacy Choice: Prices for prescription medications can differ between retail pharmacies. Some patients may find lower prices through mail-order services or by using pharmacy discount programs.

Because flutamide is a prescription-only medication, it must be ordered by a healthcare provider. Patients are encouraged to check with their insurance provider or local pharmacist to determine the exact cost under their specific plan.